Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice

Compared to classical chemotherapy, peptide-based drug targeting is a promising therapeutic approach for cancer, which can provide increased selectivity and decreased side effects to anticancer drugs. Among various homing devices, gonadotropin-releasing hormone-III (GnRH-III) peptide represents a su...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapuvári, Bence, Hegedüs, Rózsa, Schulcz, Ákos, Manea, Marilena, Tóvári, József, Gacs, Alexandra, Vincze, Borbála, Mező, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919375/
https://www.ncbi.nlm.nih.gov/pubmed/27146514
http://dx.doi.org/10.1007/s10637-016-0354-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919375/
https://www.ncbi.nlm.nih.gov/pubmed/27146514
http://dx.doi.org/10.1007/s10637-016-0354-7

Ejemplares similares